MiRus spine implants are distributed through leading hospitals and surgery centers around the country.
“Biospectal OptiBP is a breakthrough technology that enables more accessible, effective, and efficient patient monitoring to empower patients to contribute to, and participate in, the clinical regimen for chronic condition monitoring and management,” said Tim Juergens, General Manager, and co-founder, SeedLink.
The funds will be used to expand the company’s corporate footprint and US commercial acceleration of Glacial Rx™, its first-to-market revolutionary CryoAesthetic™ treatment, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation.
BIRD Foundation- Israel-U.S. Binational Industrial R&D Foundation to Invest $6 Mil in 6 New Projects
The approved projects involve innovations in the areas of Advanced Manufacturing, Communications, Cyber Security, Healthcare IT, Medical Devices, and others.
Sweetch Secures $20 Million Series A to Accelerate Fully Automated Hyper-Personalized Engagement Between Health Ecosystem Players and People with Chronic Conditions
The Series A was led by Entrée Capital. It was joined by Tal Capital, Netherlands-based impact investor Noaber, Brazil-based Kortex Ventures, and Insurtech VC FinTLV Ventures, as well as existing investors Philips, OurCrowd and Qure Ventures.
Intuitap Medical Close Successful $5.5m Series a Round of Funding Led by the Pink Ceiling and Curate Capital
This latest raise will be used to take IntuiTap's novel VerTouch technology through final clinical trials at the University of Texas, the Medical University of South Carolina, and Rhode Island Hospital, and through a submission to the FDA for approval.
Accelerating the development of company's elegant valve replacement solution for mitral and tricuspid applications.